A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...

Adding the drug enzalutamide to standard hormone therapy reduced deaths by more than 40% in men with recurrent prostate ...

A new study underway at St. David’s Surgical Hospital could help men recover faster and live a better quality of life after ...

Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...

Among patients with prostate cancer with homologous recombination repair mutations (HRRm) receiving Akeega (niraparib and ...

A hospital has performed a record number of pioneering prostate procedures in one day in a bid to help curb NHS waiting lists ...

Prostate cancer is the second most common cancer diagnosis in men. 1 in 8 men will be diagnosed with the disease during their ...

Enlarged prostate is a common non-cancerous condition that affects older men but many patients wait months for care.